| Type of Hematopoietic Stem    Cell Transplant | Source of Stem Cells | Risk of Early Infection:    Neutrophil Depletion | Risk of Late Infection:    Impaired T and B Cell Function | Risk of Ongoing Infection:    GVHD and Iatrogenic Immunosuppression | Graft versus Tumor Effect | 
      
        | Autologous | Recipient    (self) | High risk;    neutrophil recovery sometimes prolonged | 1 year | Minimal to no    risk of GVHD and late-onset severe infection | None (-) | 
      
        | Syngeneic    (genetic twin) | Identical    twin | Low risk; 1-2    weeks for recovery | 1 year | Minimal risk    of GVHD and late-onset severe infection | +/- | 
      
        | Allogeneic    related | Sibling | Low risk; 1-2    weeks for recovery | 1 year | Minimal to    moderate risk of GVHD and late-onset severe infection | ++ | 
      
        | Allogeneic    related | Child/parent(haploidentical) | Intermediate    risk; 2-3 weeks for neutrophil recovery | 1-2 years | Moderate risk    of GVHD and late-onset severe infection | ++++ | 
      
        | Allogeneic    unrelated adult | Unrelated    donor | Intermediate    risk; 2-3 weeks for neutrophil recovery | 1-2 years | High risk of    GVHD and late-onset severe infection | ++++ | 
      
        | Allogeneic    unrelated cord blood | Unrelated    cord blood units (x2) | Intermediate    to high risk; neutrophil recovery sometimes prolonged | Prolonged | Minimal to    moderate risk of GVHD and late-onset severe infection | ++++ | 
      
        | Allogeneic    mini (nonmyeloablative) | Donor    (transiently coexisting with recipient cells) | Low risk;    neutrophil counts close to normal | 1-2+ years | Variable risk    of GVHD and late-onset severe infection | ++++ (but    develops slowly) |